[HTML][HTML] Serum microRNA‑592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z Pan, L Miao - Oncology letters, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z Pan, L Miao - Oncology letters, 2020 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.
Z Pan, L Miao - Oncology Letters, 2020 - search.ebscohost.com
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.
Z Pan, L Miao - Oncology Letters, 2020 - europepmc.org
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z Pan, L Miao - Oncology Letters, 2020 - ingentaconnect.com
Colorectal cancer (CRC) is the second leading cause of cancerassociated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
[PDF][PDF] Serum microRNA‑592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z PAN, LIN MIAO - ONCOLOGY LETTERS, 2020 - pdfs.semanticscholar.org
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z Pan, L Miao - Oncology Letters, 2020 - search.proquest.com
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer.
Z Pan, L Miao - Oncology Letters, 2020 - go.gale.com
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
[HTML][HTML] Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Z Pan, L Miao - Oncology Letters, 2020 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …
worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific …